Alteplase



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Ischaemic Stroke 32.1%
Acute Myocardial Infarction 15.5%
Product Used For Unknown Indication 9.4%
Pulmonary Embolism 6.5%
Cerebrovascular Accident 5.6%
Retinal Haemorrhage 4.8%
Embolic Stroke 4.7%
Cerebral Artery Occlusion 2.4%
Myocardial Infarction 2.4%
Deep Vein Thrombosis 2.2%
Peripheral Ischaemia 2.2%
Cerebral Infarction 2.1%
Anticoagulant Therapy 1.7%
Thrombotic Cerebral Infarction 1.5%
Age-related Macular Degeneration 1.3%
Intraventricular Haemorrhage 1.2%
Peripheral Arterial Occlusive Disease 1.2%
Antiplatelet Therapy 1.0%
Hypertension 1.0%
Thrombosis 1.0%
Death 36.8%
Haemorrhage Intracranial 7.3%
Neurological Decompensation 5.9%
Cerebral Haemorrhage 5.8%
Drug Ineffective 4.6%
Cerebral Infarction 4.1%
Pulmonary Embolism 4.1%
Haemorrhagic Transformation Stroke 3.6%
Myocardial Infarction 3.1%
Vitreous Haemorrhage 2.7%
Haemorrhage 2.5%
Ischaemic Stroke 2.4%
Pneumonia 2.4%
Retinal Detachment 2.4%
Shock 2.4%
Sepsis 2.2%
Angioedema 2.0%
Cerebrovascular Accident 2.0%
Subarachnoid Haemorrhage 2.0%
Reocclusion 1.9%
Secondary
Product Used For Unknown Indication 14.9%
Acute Myocardial Infarction 14.7%
Ischaemic Stroke 12.5%
Drug Use For Unknown Indication 10.1%
Pulmonary Embolism 7.7%
Retinal Haemorrhage 6.8%
Hypertension 3.7%
Anticoagulant Therapy 3.3%
Thrombolysis 3.1%
Peripheral Ischaemia 2.9%
Off Label Use 2.6%
Cerebrovascular Accident 2.2%
Prophylaxis 2.2%
Thrombosis Prophylaxis 2.2%
Antiplatelet Therapy 2.0%
Deep Vein Thrombosis 2.0%
Acute Myeloid Leukaemia 1.8%
Cerebral Artery Occlusion 1.8%
Cerebral Infarction 1.8%
Embolism Arterial 1.8%
Death 28.4%
Haemorrhage Intracranial 6.9%
Intraocular Pressure Increased 6.9%
Cerebral Haematoma 5.9%
Ischaemic Stroke 5.9%
Drug Ineffective 4.9%
Anaphylactoid Shock 3.9%
Endophthalmitis 3.9%
Sepsis 3.9%
Cerebral Haemorrhage 2.9%
Haemorrhagic Transformation Stroke 2.9%
Pulmonary Embolism 2.9%
Shock 2.9%
Upper Gastrointestinal Haemorrhage 2.9%
Urticaria 2.9%
Vascular Pseudoaneurysm 2.9%
Vomiting 2.9%
Angioedema 2.0%
Aphasia 2.0%
Cardiac Valve Prosthesis User 2.0%
Concomitant
Product Used For Unknown Indication 33.8%
Drug Use For Unknown Indication 27.8%
Pain 6.1%
Adverse Event 5.4%
Multiple Myeloma 5.3%
Nausea 3.0%
Prophylaxis 2.5%
Constipation 2.3%
Anxiety 1.7%
Plasma Cell Myeloma 1.6%
Hypertension 1.4%
Deep Vein Thrombosis 1.3%
Nuclear Magnetic Resonance Imaging 1.3%
Supplementation Therapy 1.1%
Breast Cancer 1.0%
Gastrooesophageal Reflux Disease 1.0%
Graft Versus Host Disease 0.9%
Anaemia 0.9%
Blood Pressure Abnormal 0.9%
Metastases To Bone 0.8%
Vomiting 8.9%
Wound Drainage 8.9%
Venous Occlusion 7.6%
Tricuspid Valve Incompetence 6.3%
Aspartate Aminotransferase Increased 5.1%
Nephrogenic Systemic Fibrosis 5.1%
Pneumonia 5.1%
Sepsis 5.1%
Thrombocytopenia 5.1%
Weight Decreased 5.1%
Neutropenic Sepsis 3.8%
Osteomyelitis 3.8%
Pulmonary Embolism 3.8%
Pyrexia 3.8%
Renal Failure Acute 3.8%
Respiratory Failure 3.8%
Skin Tightness 3.8%
Tumour Lysis Syndrome 3.8%
Vision Blurred 3.8%
Visual Impairment 3.8%
Interacting
Product Used For Unknown Indication 33.3%
Atrial Fibrillation 16.7%
Cerebrovascular Accident Prophylaxis 16.7%
Hypertension 16.7%
Ischaemic Stroke 16.7%
Drug Interaction 60.0%
Ischaemic Stroke 40.0%